Publications of Faculty of Medicine:THE ROLE OF DENVER PERITONEO-VENOUS SHUNT IN MANAGEMENT OF PATIENTS WITH REFRACTORY ASCITES: Abstract

Title:
THE ROLE OF DENVER PERITONEO-VENOUS SHUNT IN MANAGEMENT OF PATIENTS WITH REFRACTORY ASCITES
Full paper Not Available
Abstract:

Faculty of Medicine. Zaggazig University.. Egypt Introduction: Refractory ascites constitutes 15% of all patients suffering from ascites. It is associated with great morbidity, repeated hospitalization and poor quality of life. Recently, better understanding of pathophysiological changes associated with ascites that could be reversed by shunting of the, ascetic fluid into the systemic circulation as well as the development in the pen-operative management that could overcome and prevent certain serious complications resulted in reappraisal of Denver shunt for treatment of refractory ascites. The aim of this study is to define those patients suffering from refractory ascites who can benefit from peritoneo-venous shunting of ascites using Denver shunt. Methods: Thirty-five patients with refractory ascites were selected for peritoneo-venous shunt (P. V.5) according to certain criteria including: Pugh score <10. platelet count >70z109 / L. serum fibrinogen >230mg/ di and micro-organism free ascetic fluid on culture. All patients had pre-operative tapping and partial replacement of ascetic fluid with lactated Ringer's solution into the peritoneal cavity. Results: Thirty-five patients (28 males and 7 females) with a mean age of 41 years had Denver shunts. A mean volume of 7.5 L. of ascetic fluid was removed and replaced in half pre-operatively. Peri-operative mortality was 5.6% due to coagulopathy and septicaemia. One patient had congestive heart failure and 2 patients had episodes of variceal bleeding. the mean hospital stay was 6 days and the mean follow-up period was 18 months. The serum albumin level improved in 82.896 of patients With a mean rise of 0.8 gm / dl. The mean loss of weight due to ascetic .fluid shunting was 6.5 kg associated with reduction of abdominal girth by a mean of 40% after one month. The shunt was functioning in 100% of patients after 6 month. 94% O'er 12 months and 91% after 18 months. A questionnaire proved better quality of life after P.V.S. Conclusion: P.V.S is effective in palliation of refractory ascites. The outcome is basically dependant on the functional hepatic reserve, hence proper selection of patients is of prime importance to get a favourable outcome.